Fisiopatologia i tractament de les malalties neurodegeneratives
Publicacions destacades
-
Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration
Ballasch, I; García-García, E; Pérez-González, A; Sancho-Balsells, A; Fernández, J;(...)Alberch, J; Rodríguez, MJ; Giralt, A; Vila, C; Canals, JM.Referència:Brain Behavior And Immunity 2023.
-
GPC3-Unc5 receptor complex structure and role in cell migration
Akkermans, Onno; Delloye-Bourgeois, Celine; Peregrina, Claudia; Carrasquero-Ordaz, Maria; Kokolaki, Maria;(...)Robinson, Carol V; Robinson, Carol V; Castellani, Valerie; del Toro, Daniel; Seiradake, Elena.Referència:Cell 2022.
-
Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington's disease mice
Pupak, A; Sancho-Balsells, A; Espina, M; Giralt, A; Martí, E;Ginés, S; Brito, V; Singh, A; Orom, UAV; Alcalá-Vida, R.Referència:Cellular And Molecular Life Sciences 2022.
-
Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder
Rosser, AE; Gray, WP; Busse, ME; Mills, LJ; Drew, C;(...)Martin, UP; Salado-Manzano, C; Canals, JM; Goldman, SA; Thompson, LM.Referència:Brain 2022.
-
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice
Creus-Muncunill, J; Guisado-Corcoll, A; Escaramís, G; de Herreros, MG; Solaguren-Beascoa, M;(...)Llorens, F; Diaz-Lucena, D; Venturi, V; Navarrete, C; Pantano, L.Referència:Acta Neuropathologica 2021.
-
Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease
Alcalá-Vida, R; Garcia-Forn, M; Castany-Pladevall, C; Creus-Muncunill, J; Ito, Y;(...)Samarajiwa, S; Peiró, S; Di Croce, L; Narita, M; Pérez-Navarro, E.Referència:Embo Molecular Medicine 2021.
-
M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease
Fernandez-Garcia, Sara; Conde-Berriozabal, Sara; Garcia-Garcia, Esther; Gort-Paniello, Clara; Bernal-Casas, David;(...)Campa, Leticia; Artigas, Francesc; Jose Rodriguez, Manuel; Alberch, Jordi; Masana, Merce.Referència:Elife 2020.
-
Increased translation as a novel pathogenic mechanism in Huntington's disease
Creus-Muncunill, Jordi; Badillos-Rodriguez, Raquel; Garcia-Forn, Marta; Masana, Merce; Garcia-Diaz Barriga, Gerardo;(...)Alberch, Jordi; Malagelada, Cristina; Delgado-Garcia, Jose M; Gruart, Agnes; Perez-Navarro, Esther.Referència:Brain 2019.
-
Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens
Brito, Veronica; Giralt, Albert; Masana, Merce; Royes, Aida; Espina, Marc;Sieiro, Esther; Alberch, Jordi; Castane, Anna; Girault, Jean-Antoine; Gines, Silvia.Referència:Biological Psychiatry 2019.
-
Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.
Cariulo C; Azzollini L; Verani M; Martufi P; Boggio R;(...)Santimone I; Squitieri F; Lashuel HA; Petricca L; Caricasole A .Referència:Proceedings Of The National Academy Of Sciences Of The United States Of America 2017.